Updated cost-of-care estimates for commercially insured patients with multiple sclerosis: retrospective observational analysis of medical and pharmacy claims data

Table 1 Disease-modifying drugs for multiple sclerosis

^aDrugs were identified by brand names on pharmacy claims and HCPCS codes on medical claims.
^bIndicates a DMD included in the study by Prescott et al. [10].
DMD = disease-modifying drug; HCPCS = Healthcare Common Procedure Coding System; IFN = interferon; IM = intramuscular; SC = subcutaneous.

ISSN: 1472-6963